A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...

A study identifies beta-synuclein in blood as a potential early biomarker for Alzheimer’s disease. This protein’s levels rise ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic ...

Interleukin-6 could help physicians diagnose sepsis early in children and pregnant women, according to a real-world study presented at the ESCMID Global meeting 2025.“Traditional biomarkers have a lag ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

The following is a summary of "Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis," published ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...